Particle number analysis of lipoprotein subclasses by gel permeation HPLC in patients with cholesteryl ester transfer protein deficiency

We previously reported that patients with cholesteryl ester transfer protein (CETP) deficiency (CETP-D) have a higher prevalence of atherosclerotic cardiovascular disease, in spite of increased HDL-C levels. However, characterization of HDL in CETP-D has not been well described. Therefore, we examin...

Full description

Saved in:
Bibliographic Details
Published inPloS one Vol. 13; no. 1; p. e0190875
Main Authors Okada, Takeshi, Ohama, Tohru, Okazaki, Mitsuyo, Kanno, Kotaro, Matsuda, Hibiki, Sairyo, Masami, Zhu, Yinghong, Saga, Ayami, Kobayashi, Takuya, Masuda, Daisaku, Koseki, Masahiro, Nishida, Makoto, Sakata, Yasushi, Yamashita, Shizuya
Format Journal Article
LanguageEnglish
Published United States Public Library of Science 05.01.2018
Public Library of Science (PLoS)
Subjects
Online AccessGet full text
ISSN1932-6203
1932-6203
DOI10.1371/journal.pone.0190875

Cover

More Information
Summary:We previously reported that patients with cholesteryl ester transfer protein (CETP) deficiency (CETP-D) have a higher prevalence of atherosclerotic cardiovascular disease, in spite of increased HDL-C levels. However, characterization of HDL in CETP-D has not been well described. Therefore, we examined HDL particle number (PN) rather than HDL-C level. Nine patients with CETP-D and 9 normolipidemic subjects were enrolled. We performed gel permeation high-performance liquid chromatography (GP-HPLC) analysis, determined the cholesterol and triglyceride composition of all lipoprotein subclasses, and calculated the PN of each subclass, which consisted of 3 VLDL (large, medium, and small), 4 LDL (large, medium, small, and very small), and 5 HDL (very large, large, medium, small, and very small) subclasses. The PNs of large and medium LDL were significantly lower in CETP-D than that in healthy subjects (0.66- and 0.63-fold decrease, respectively; p<0.001), whereas the PN of very small LDL, which is known to be atherogenic, was significantly higher (1.36-fold increase, p = 0.016). The PNs of very large and large HDL in CETP-D were markedly higher than that in healthy subjects (19.9- and 4.5-fold increase, respectively; p<0.001), whereas the PNs of small and very small HDL, which have more potent anti-atherogenic functions, were significantly lower (0.76- and 0.61-fold decrease, respectively; p<0.001). We have assessed the PNs of detailed subclasses of patients with CETP-D for the first time. The PN of larger HDL was markedly increased, that of smaller HDL was decreased, and that of very small LDL was increased, suggesting that CETP-D has pro-atherogenic lipoprotein properties.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
content type line 23
Competing Interests: MO and SY received consultant fee from Skylight Biotech Inc., but are not employees of the company. MD and SY received research grants from Merck Sharp and Dohme Inc. The patent by MO (Publication number: WO/2015/152371) belongs to Skylight Biotech Inc.
ISSN:1932-6203
1932-6203
DOI:10.1371/journal.pone.0190875